{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T10:35:27Z","timestamp":1794393327116,"version":"4.9.0"},"reference-count":180,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ejmech.2025.117472","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T02:37:28Z","timestamp":1740969448000},"page":"117472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["A systematic review on the anti-microbial activities and structure-activity relationship (SAR) of quinoxaline derivatives"],"prefix":"10.1016","volume":"289","author":[{"given":"Sri Mounika","family":"Bellapukonda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rani","family":"Bandela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Singampalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danaboina","family":"Srikanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pardeep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Nanduri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9813-8694","authenticated-orcid":false,"given":"Venkata Madhavi","family":"Yaddanapudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117472_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118579","article-title":"Roles of long noncoding RNAs in bacterial infection","volume":"263","author":"Wen","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2025.117472_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116675","article-title":"Exploring quinoxaline derivatives: an overview of a new approach to combat antimicrobial resistance","volume":"276","author":"Khatoon","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113858","article-title":"A molecular approach to the discovery of potent and non-toxic rhenium complexes active against C. albicans-MRSA co-infection","volume":"226","author":"Sovari","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115026","article-title":"Current scenario of quinolone hybrids with potential antibacterial activity against ESKAPE pathogens","volume":"247","author":"Gao","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114513","article-title":"Marine natural products and their synthetic analogs as promising antibiofilm agents for antibiotics discovery and development","volume":"239","author":"Deng","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117008","article-title":"Multidrug-resistant bacteria quorum-sensing inhibitors: a particular focus on Pseudomonas aeruginosa","volume":"281","author":"Maiga","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115689","article-title":"Thiazole-based analogues as potential antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA) and their SAR elucidation","volume":"259","author":"Guo","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112686","article-title":"1,2,3-Triazole-containing hybrids with potential antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"206","author":"Xu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004264","article-title":"Antimicrobial resistance: addressing a global threat to Humanity","volume":"20","author":"Walsh","year":"2023","journal-title":"PLoS Med."},{"key":"10.1016\/j.ejmech.2025.117472_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117081","article-title":"Antibacterial and antifungal pyrazoles based on different construction strategies","volume":"282","author":"Rehman","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/ffunb.2024.1339911","article-title":"Healthcare-associated fungal infections and emerging pathogens during the COVID-19 pandemic","volume":"5","author":"Shah","year":"2024","journal-title":"Front. Fungal Biol"},{"key":"10.1016\/j.ejmech.2025.117472_bib12","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.117472_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116785","article-title":"Recent advances and challenges of revolutionizing drug-resistant tuberculosis treatment","volume":"277","author":"Wei","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115927","article-title":"Synthetic product-based approach toward potential antileishmanial drug development","volume":"263","author":"Pal","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib15","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1016\/j.vaccine.2023.01.057","article-title":"Vaccine value profile for leishmaniasis","volume":"41","author":"Kaye","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.ejmech.2025.117472_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105849","article-title":"A comprehensive review on potential therapeutic inhibitors of nosocomial Acinetobacter baumannii superbugs","volume":"124","author":"Srikanth","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib17","doi-asserted-by":"crossref","first-page":"5844","DOI":"10.3390\/ijms20235844","article-title":"Strategies to overcome antimicrobial resistance (AMR) making use of non-essential target inhibitors: a review","volume":"20","author":"Annunziato","year":"2019","journal-title":"IJMS"},{"key":"10.1016\/j.ejmech.2025.117472_bib18","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.3390\/molecules24213839","article-title":"Heterocycles in medicinal chemistry","volume":"24","author":"Jampilek","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117472_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400902","article-title":"Design, synthesis and biological evaluation of ethyl 5\u2010(1\u2010benzyl\u20101 H \u2010indol\u20105\u2010yl) isoxazole\u20103\u2010carboxylates as antimycobacterial agents","author":"Bandela","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.117472_bib20","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.3390\/molecules26164742","article-title":"Quinoxaline moiety: a potential scaffold against Mycobacterium tuberculosis","volume":"26","author":"Montana","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117472_bib21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijantimicag.2017.04.016","article-title":"In vitro and in vivo assessment of newer quinoxaline\u2013 oxadiazole hybrids as anti-microbial and anti-protozoal agents","volume":"50","author":"Patel","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2025.117472_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.137041","article-title":"Design, synthesis and biological evaluation of newly triazolo-quinoxaline based potential immunomodulatory anticancer molecules","volume":"1298","author":"Ward","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117472_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2023.100783","article-title":"Analgesic and anti-inflammatory activity of quinoxaline derivatives: design synthesis and characterization","volume":"5","author":"Meka","year":"2023","journal-title":"Results in Chemistry"},{"key":"10.1016\/j.ejmech.2025.117472_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.130175","article-title":"Novel molecular hybrids of EGCG and quinoxaline: potent multi-targeting antidiabetic agents that inhibit \u03b1-glucosidase, \u03b1-amylase, and oxidative stress","volume":"263","author":"Kothari","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2025.117472_bib25","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1080\/17568919.2024.2419354","article-title":"Design, synthesis and mechanistic exploration of anti-plasmodial Indolo[2,3- b ]quinoxaline-7-chloroquinoline hybrids","volume":"16","author":"Chowdhary","year":"2024","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib26","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2024.2413018","article-title":"Expanding the antiprotozoal activity and the mechanism of action of n-butyl and iso-butyl ester of quinoxaline-1,4-di- N -oxide derivatives against Giardia lamblia , Trichomonas vaginalis , and Entamoeba histolytica. An in vitro and in silico approach","volume":"39","author":"Gonz\u00e1lez-Gonz\u00e1lez","year":"2024","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/12298093.2024.2362497","article-title":"Antifungal activity of 3-hydrazinoquinoxaline-2-thiol, a novel quinoxaline derivative against Candida species","volume":"52","author":"Elfadil","year":"2024","journal-title":"MYCOBIOLOGY"},{"key":"10.1016\/j.ejmech.2025.117472_bib28","doi-asserted-by":"crossref","first-page":"14791","DOI":"10.1039\/D4NJ03143A","article-title":"Quinoxaline derivatives as potent compounds against both 3CLpro and PLpro enzymes of SARS-CoV-2 virus: an insight from experimental and theoretical approaches","volume":"48","author":"Noroozi-Shad","year":"2024","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib29","series-title":"Advances in Food and Nutrition Research","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/bs.afnr.2017.11.002","article-title":"Riboflavin in human health: a review of current evidences","author":"Saedisomeolia","year":"2018"},{"key":"10.1016\/j.ejmech.2025.117472_bib30","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3390\/ijms21030950","article-title":"Riboflavin: the health benefits of a forgotten natural vitamin","volume":"21","author":"Suwannasom","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.ejmech.2025.117472_bib31","first-page":"117","article-title":"Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension","volume":"3","author":"Galanopoulos","year":"2009","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.ejmech.2025.117472_bib32","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1517\/14656566.1.4.815","article-title":"The evolving pharmacotherapeutic profile of brimonidine, an 2-adrenergic agonist, after four years of continuous use","volume":"1","author":"Cantor","year":"2000","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.117472_bib33","doi-asserted-by":"crossref","first-page":"176","DOI":"10.18203\/2319-2003.ijbcp20164775","article-title":"A clinical study on role of caroverine in the management of tinnitus","volume":"6","author":"Kumari","year":"2016","journal-title":"Int. J. Basic Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117472_bib34","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1158\/1078-0432.CCR-18-3334","article-title":"Multicenter phase I study of erdafitinib (JNJ-42756493), oral pan-fibroblast growth factor receptor inhibitor, in patients with advanced or refractory solid tumors","volume":"25","author":"Bahleda","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.117472_bib35","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0021-5155(02)00698-6","article-title":"Platelet-derived growth factor receptor kinase inhibitor AG1295 and inhibition of experimental proliferative vitreoretinopathy","volume":"47","author":"Zheng","year":"2003","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.ejmech.2025.117472_bib36","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2147\/OTT.S70691","article-title":"Tyrphostin AG1296, a platelet-derived growth factor receptor inhibitor, induces apoptosis, and reduces viability and migration of PLX4032-resistant melanoma cells","author":"Li","year":"2015","journal-title":"OTT"},{"key":"10.1016\/j.ejmech.2025.117472_bib37","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3390\/cancers12030731","article-title":"Tyrosine kinase inhibitors in cancer: breakthrough and challenges of targeted therapy","volume":"12","author":"Pottier","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2025.117472_bib38","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.etap.2012.10.003","article-title":"Quinalphos induced oxidative stress and histoarcheitectural alterations in adult male albino rats","volume":"34","author":"Subramaneyaan","year":"2012","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117472_bib39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.aquatox.2016.09.018","article-title":"Toxicomorphomics and toxicokinetics of quinalphos on embryonic development of zebrafish (Danio rerio) and its binding affinity towards hatching enzyme, ZHE1","volume":"180","author":"Yashwanth","year":"2016","journal-title":"Aquat. Toxicol."},{"key":"10.1016\/j.ejmech.2025.117472_bib40","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1021\/acsagscitech.1c00260","article-title":"Metabolism and tissue depletion of carbadox in swine, broilers, and rats","volume":"2","author":"Zhang","year":"2022","journal-title":"ACS Agric. Sci. Technol."},{"key":"10.1016\/j.ejmech.2025.117472_bib41","doi-asserted-by":"crossref","first-page":"12518","DOI":"10.1073\/pnas.0705368104","article-title":"Varenicline, an \u03b14\u03b22 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking","volume":"104","author":"Steensland","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2025.117472_bib42","first-page":"435","article-title":"Varenicline for smoking cessation: a narrative review of efficacy, adverse effects, use in at-risk populations, and adherence","volume":"10","author":"Burke","year":"2016","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.ejmech.2025.117472_bib43","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/003693306601100505","article-title":"Quinacillin: a study of a new penicillin","volume":"11","author":"Christie","year":"1966","journal-title":"Scott. Med. J."},{"key":"10.1016\/j.ejmech.2025.117472_bib44","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0022-3565(25)20367-6","article-title":"Behavioral effects of U-78875, a quinoxalinone anxiolytic with potent benzodiazepine antagonist activity","volume":"259","author":"Tang","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ejmech.2025.117472_bib45","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0376-8716(00)00142-3","article-title":"Discriminative stimulus effects of panadiplon (U-78875), a partial agonist at the benzodiazepine site, in pentobarbital-trained rhesus monkeys","volume":"61","author":"Rowlett","year":"2001","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ejmech.2025.117472_bib46","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1124\/jpet.104.080275","article-title":"Contribution of \u03b1 1 gaba A and \u03b1 5 gaba A receptor subtypes to the discriminative stimulus effects of ethanol in squirrel monkeys","volume":"313","author":"Platt","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ejmech.2025.117472_bib47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12603-011-0012-x","article-title":"Progress in the development of new drugs in Alzheimer\u2019 s disease","volume":"15","author":"Piau","year":"2011","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.ejmech.2025.117472_bib48","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2025.117472_bib49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.expneurol.2008.01.011","article-title":"The Role of AMPA receptor modulation in the treatment of neuropsychiatric diseases","volume":"211","author":"Zarate","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejmech.2025.117472_bib50","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1016\/0006-2952(89)90123-8","article-title":"Immunosuppressive properties of chloroquinoxaline sulfonamide","volume":"38","author":"Branda","year":"1989","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117472_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00873904","article-title":"Chloroquinoxaline sulfonamide: a sulfanilamide antitumor agent entering clinical trials","volume":"11","author":"Fisherman","year":"1993","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.ejmech.2025.117472_bib52","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/bjc.1993.220","article-title":"SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours","volume":"67","author":"Brown","year":"1993","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejmech.2025.117472_bib53","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3390\/pharmaceutics14040847","article-title":"Improving tirapazamine (TPZ) to target and eradicate hypoxia tumors by gold nanoparticle carriers","volume":"14","author":"Ajnai","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2025.117472_bib54","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.ejca.2008.05.018","article-title":"A phase I and pharmacokinetic study of the quinoxaline antitumour Agent R(+)XK469 in patients with advanced solid tumours","volume":"44","author":"Undevia","year":"2008","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejmech.2025.117472_bib55","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/toxsci\/kfae008","article-title":"Exploring the effects of topoisomerase II inhibitor XK469 on anthracycline cardiotoxicity and DNA damage","volume":"198","author":"Kereste\u0161","year":"2024","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejmech.2025.117472_bib56","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/epi4.12549","article-title":"The AMPA receptor antagonist perampanel suppresses epileptic activity in human focal cortical dysplasia","volume":"7","author":"Brito da Silva","year":"2022","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.ejmech.2025.117472_bib57","doi-asserted-by":"crossref","DOI":"10.1634\/theoncologist.2016-0257","article-title":"Phase I dose-escalation study of pilaralisib (SAR245408, XL147) in combination with paclitaxel and carboplatin in patients with solid tumors","volume":"22","author":"Wheler","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.ejmech.2025.117472_bib58","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ygyno.2014.12.019","article-title":"Phase II study of the PI3K inhibitor pilaralisib (SAR245408; XL147) in patients with advanced or recurrent endometrial carcinoma","volume":"136","author":"Matulonis","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ejmech.2025.117472_bib59","first-page":"1874","article-title":"Fused heterocycles as a potent biological agents; recent advancement","volume":"7","author":"Upendra","year":"2019","journal-title":"IJPSR"},{"key":"10.1016\/j.ejmech.2025.117472_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117901","article-title":"Synthesis and antibacterial activities of heterocyclic ring-fused 20(S)-protopanaxadiol derivatives","volume":"112","author":"Zhang","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1102225","article-title":"Exploring plant polyphenols as anti-allergic functional products to manage the growing incidence of food allergy","volume":"10","author":"Wu","year":"2023","journal-title":"Front. Nutr."},{"key":"10.1016\/j.ejmech.2025.117472_bib62","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/scipharm91020026","article-title":"Fused triazole-azepine hybrids as potential non-steroidal antiinflammatory agents","volume":"91","author":"Demchenko","year":"2023","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.ejmech.2025.117472_bib63","first-page":"369","volume":"vol. 20","author":"Biswas","year":"2024"},{"key":"10.1016\/j.ejmech.2025.117472_bib64","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/jhet.2396","article-title":"Synthesis, docking, and evaluation of antimicrobial activity of a new series of acyclo C\u2010 nucleosides of 1, 2, 4\u2010 triazolo[4, 3\u2010 a ]quinoxaline derivatives","volume":"53","author":"Ayoup","year":"2016","journal-title":"Journal of Heterocyclic Chem"},{"key":"10.1016\/j.ejmech.2025.117472_bib65","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.4155\/fmc-2018-0082","article-title":"Synthesis of pyrazolo-1,2,4-triazolo[4,3- a ]quinoxalines as antimicrobial agents with potential inhibition of DHPS enzyme","volume":"10","author":"Z El-Attar","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103656","article-title":"Antimicrobial screening and pharmacokinetic profiling of novel phenyl-[1,2,4]triazolo[4,3-a]quinoxaline analogues targeting DHFR and E. coli DNA gyrase B","volume":"96","author":"Omar","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib67","doi-asserted-by":"crossref","first-page":"19805","DOI":"10.3390\/molecules201119655","article-title":"Synthesis, characterization and biological evaluation of SomeQuinoxaline derivatives: a promising and potent new class of antitumor and antimicrobial agents","volume":"20","author":"Al-Marhabi","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117472_bib68","first-page":"627","article-title":"Synthesis, characterization and antimicrobial activity of boron, silicon and selenium substituted quinoxaline derivatives","volume":"8","author":"Basha","year":"2019","journal-title":"PharmaJournal"},{"key":"10.1016\/j.ejmech.2025.117472_bib69","doi-asserted-by":"crossref","first-page":"83901","DOI":"10.1039\/C6RA15425E","article-title":"Efficient synthesis of 2-phenyl-3-substituted furo\/thieno[2,3-b]quinoxalines via Sonogashira coupling reaction followed by iodocyclization and subsequent palladium-catalyzed cross-coupling reactions","volume":"6","author":"Besharati-Seidani","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.117472_bib70","doi-asserted-by":"crossref","first-page":"S387","DOI":"10.1016\/j.jscs.2012.12.011","article-title":"Heterocyclic systems containing bridgehead nitrogen atom: synthesis and antimicrobial activity of thiadiazolo[2\u2032 ,3\u2032 :2,3]imidazo[4,5-B]quinoxaline","volume":"20","author":"Teja","year":"2016","journal-title":"J. Saudi Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117472_bib71","first-page":"445","article-title":"Design, synthesis and biological evaluation of 2,3-disubstituted and fused quinoxalines as potential anticancer and antimicrobial agents","volume":"74","author":"Abbas Hany","year":"2017","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.ejmech.2025.117472_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104164","article-title":"Design, synthesis, antimicrobial activity and molecular docking studies of some novel ,di-substituted sulfonylquinoxaline derivatives","volume":"104","author":"Ammar","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib73","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.3390\/molecules24101962","article-title":"Domino multicomponent approach for the synthesis of functionalized spiro-indeno[1,2-b]quinoxaline heterocyclic hybrids and their antimicrobial activity, synergistic effect and molecular docking simulation","volume":"24","author":"Abdulrahman","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117472_bib74","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1080\/00397911.2020.1786122","article-title":"Synthesis and characterization of N\u2032 -(11 H -indeno[1,2-b ]quinoxalin-11-ylidene) benzohydrazonamides as potential antimicrobial agents","volume":"50","author":"Gomaa","year":"2020","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2025.117472_bib75","doi-asserted-by":"crossref","first-page":"276","DOI":"10.17344\/acsi.2019.5437","article-title":"Synthesis, characterization and antimicrobial evaluation of novel 6\u2019 -Amino-spiro[indeno[1,2-b] quinoxaline[1,3]dithiine]-5\u2019 -carbonitrile derivatives","volume":"67","author":"Moghaddam-Manesh","year":"2020","journal-title":"ACSi"},{"key":"10.1016\/j.ejmech.2025.117472_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.130309","article-title":"Synthesis, characterization, theoretical, and antimicrobial studies of indenoquinoxalin-based ligands and their reactions with CuBr(PPh3)3","volume":"1238","author":"Babgi","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117472_bib77","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3390\/catal12020213","article-title":"Modified 7-chloro-11H-indeno[1,2-b]quinoxaline heterocyclic system for biological activities","volume":"12","author":"Kumar","year":"2022","journal-title":"Catalysts"},{"key":"10.1016\/j.ejmech.2025.117472_bib78","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.3390\/molecules27217248","article-title":"Multifunctional derivatives of spiropyrrolidine tethered indeno-quinoxaline heterocyclic hybrids as potent antimicrobial, antioxidant and antidiabetic agents: design, synthesis, in vitro and in silico approaches","volume":"27","author":"Bouali","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117472_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2021.103497","article-title":"Design, synthesis of new novel quinoxalin-2(1H)-one derivatives incorporating hydrazone, hydrazine, and pyrazole moieties as antimicrobial potential with in-silico ADME and molecular docking simulation","volume":"15","author":"Ragab","year":"2022","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2024.101350","article-title":"Recent advances in biological and medicinal profile of schiff bases and their metal complexes: an updated version (2018\u2013 2023)","volume":"7","author":"Thakur","year":"2024","journal-title":"Results in Chemistry"},{"key":"10.1016\/j.ejmech.2025.117472_bib81","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00044-023-03068-0","article-title":"Promising Schiff bases in antiviral drug design and discovery","volume":"32","author":"Kaushik","year":"2023","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2025.117472_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/1745236","article-title":"Synthesis, characterization and antibacterial activity of schiff base, 4-chloro-2-{(E)-[(4-Fluorophenyl)imino]methyl}phenol metal (II) complexes","volume":"2020","author":"Ommenya","year":"2020","journal-title":"J. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib83","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4489\/MYCO.2008.36.2.093","article-title":"Antibacterial and antifungal studies on some schiff base complexes of zinc(II)","volume":"36","author":"Joseyphus","year":"2008","journal-title":"MYCOBIOLOGY"},{"key":"10.1016\/j.ejmech.2025.117472_bib84","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.2174\/1871520619666190227171716","article-title":"Schiff bases and their metal complexes as potential anticancer candidates: a review of recent works","volume":"19","author":"Tadele","year":"2019","journal-title":"ACAMC"},{"key":"10.1016\/j.ejmech.2025.117472_bib85","doi-asserted-by":"crossref","first-page":"S322","DOI":"10.1016\/j.jscs.2014.03.006","article-title":"Synthesis, characterization and antioxidant activities of Schiff bases are of cholesterol","volume":"21","author":"Kumar","year":"2017","journal-title":"J. Saudi Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117472_bib86","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1002\/jhet.2663","article-title":"Synthesis, characterization and antimicrobial activity of 1,2\u2010 dihydroquinoxaline\u2010 3\u2010 yl\u2010 3\u2010 substitutedphenyl\u2010 1 H \u2010 pyrazole\u2010 4\u2010 carbaldehyde","volume":"54","author":"Dhanapal","year":"2017","journal-title":"Journal of Heterocyclic Chem"},{"key":"10.1016\/j.ejmech.2025.117472_bib87","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1055\/s-0043-120198","article-title":"Graph theoretical analysis, in silico modeling, synthesis, anti-microbial and anti-TB evaluation of novel quinoxaline derivatives","volume":"68","author":"Saravanan","year":"2018","journal-title":"Drug Res."},{"key":"10.1016\/j.ejmech.2025.117472_bib88","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bioorg.2017.12.017","article-title":"Design, synthesis, antibacterial evaluation and molecular docking studies of some new quinoxaline derivatives targeting dihyropteroate synthase enzyme","volume":"76","author":"El-Attar","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib89","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1007\/s00044-018-2235-4","article-title":"Design, synthesis and biological evaluation of quinoxaline N-propionic and O-propionic hydrazide derivatives as antibacterial and antifungal agents","volume":"27","author":"El Shehry","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2025.117472_bib90","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.37285\/ijpsn.2021.14.2.8","article-title":"Design, synthesis, antimicrobial evaluation and molecular docking studies of some novel monoterpenoids substituted quinoxaline thiosemicarbazide derivatives","volume":"14","author":"Bihari","year":"2021","journal-title":"PCI- Approved-IJPSN"},{"key":"10.1016\/j.ejmech.2025.117472_bib91","doi-asserted-by":"crossref","first-page":"45","DOI":"10.31782\/IJCRR.2021.131302","article-title":"Synthesis, characterization, in-vitro antimicrobial evaluation and molecular docking studies of aromatic aldehydes substituted ThiosemicarbazideQuinoxaline derivatives","volume":"13","author":"Bihari","year":"2021","journal-title":"IJCRR"},{"key":"10.1016\/j.ejmech.2025.117472_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.jics.2024.101163","article-title":"Quinoxaline clubbed thiazole: molecular docking, synthesis and antimicrobial evaluation","volume":"101","author":"Shrimandilkar","year":"2024","journal-title":"J. Indian Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117472_bib93","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/jhet.3431","article-title":"Design, synthesis, and characterization of quinoxaline derivatives as a potent antimicrobial agent","volume":"56","author":"Dewangan","year":"2019","journal-title":"Journal of Heterocyclic Chem"},{"key":"10.1016\/j.ejmech.2025.117472_bib94","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1080\/10406638.2020.1781210","article-title":"Design and synthesis of 3,6-disubstituted- and 2,3,6-trisubstitutedquinoxalines: docking and in vitro antimicrobial study","volume":"42","author":"Ismail","year":"2022","journal-title":"Polycycl. Aromat. Compd."},{"key":"10.1016\/j.ejmech.2025.117472_bib95","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3389\/fchem.2020.00598","article-title":"Design, synthesis, and biological evaluation of novel thiazolidinone-containing quinoxaline-1,4-di-N-oxides as antimycobacterial and antifungal agents","volume":"8","author":"Zhang","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib96","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/cmdc.201200585","article-title":"Carboxylic acid (Bio)Isosteres in drug design","volume":"8","author":"Ballatore","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.117472_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/2164558","article-title":"Carboxylic acid bioisosteres in medicinal chemistry: synthesis and properties","volume":"2022","author":"Bredael","year":"2022","journal-title":"J. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib98","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijantimicag.2017.04.016","article-title":"In vitro and in vivo assessment of newer quinoxaline\u2013 oxadiazole hybrids as antimicrobial and antiprotozoal agents","volume":"50","author":"Patel","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2025.117472_bib99","first-page":"433","article-title":"Design, synthesis and antimicrobial activity of amide-linked quinoxaline derivatives","volume":"13","author":"pravin","year":"2017","journal-title":"Int. J. Appl. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib100","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1002\/jhet.2896","article-title":"Antimicrobial evaluation of new quinoxaline derivatives synthesized by selective coupling with alkyl halides and amino acids esters","volume":"54","author":"Ahmed","year":"2017","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib101","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.bioorg.2017.11.019","article-title":"Design, synthesis, molecular docking of new lipophilic acetamide derivatives affording potential anticancer and antimicrobial agents","volume":"76","author":"Ahmed","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib102","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.molstruc.2019.02.074","article-title":"Quinoxaline-PABA bipartite hybrid derivatization approach: design and search for antimicrobial agents","volume":"1184","author":"Patel","year":"2019","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117472_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.864286","article-title":"Triazoles and their derivatives: chemistry, synthesis, and therapeutic applications","volume":"9","author":"Matin","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ejmech.2025.117472_bib104","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.1016\/j.bmc.2015.06.070","article-title":"Design, synthesis and immunological evaluation of 1,2,3-triazole-tethered carbohydrate\u2013 Pam 3 Cys conjugates as TLR2 agonists","volume":"23","author":"Nalla","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128800","article-title":"Synthesis of novel immunomodulatory 1,4-disubstituted bis-1,2,3-triazoles by using click chemistry and their intracellular mechanism of action","volume":"69","author":"Nural","year":"2022","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117472_bib106","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3390\/antibiotics12010160","article-title":"Coumarin triazoles as potential antimicrobial agents","volume":"12","author":"Patil","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2025.117472_bib107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/7884316","article-title":"A recent overview of 1,2,3-triazole-containing hybrids as novel antifungal agents: focusing on synthesis, mechanism of action, and structure-activity relationship (SAR)","volume":"2022","author":"Marzi","year":"2022","journal-title":"J. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib108","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s10600-022-03824-5","article-title":"Synthesis of 1,2,3-triazolyl-substituted derivatives of the alkaloids sinomenine and tetrahydrothebaine on ring A and their analgesic activity","volume":"58","author":"Finke","year":"2022","journal-title":"Chem. Nat. Compd."},{"key":"10.1016\/j.ejmech.2025.117472_bib109","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3390\/life12091341","article-title":"1,2,3-Triazole-Benzofused molecular conjugates as potential antiviral agents against SARS-CoV-2 virus variants","volume":"12","author":"Al-Humaidi","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.ejmech.2025.117472_bib110","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejmech.2019.01.047","article-title":"Triazole derivatives and their antiplasmodial and antimalarial activities","volume":"166","author":"Chu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib111","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202100158","article-title":"1,2,3\u2010 Triazole hybrids as anticancer agents: a review","volume":"355","author":"Alam","year":"2022","journal-title":"Archiv Der Pharmazie"},{"key":"10.1016\/j.ejmech.2025.117472_bib112","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/metabo11040225","article-title":"Synthesis and biological evaluation of coumarin-linked 4-anilinomethyl-1,2,3-triazoles as potent inhibitors of carbonic anhydrases IX and XIII involved in tumorigenesis","volume":"11","author":"Thacker","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.ejmech.2025.117472_bib113","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4155\/fmc-2018-0006","article-title":"Isoform selectivity of harmine-conjugated 1,2,3-triazoles against human monoamine oxidase","volume":"10","author":"Haider","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib114","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bioorg.2018.10.056","article-title":"Novel tacrine-coumarin hybrids linked to 1,2,3-triazole as anti-Alzheimer\u2019 s compounds: in vitro and in vivo biological evaluation and docking study","volume":"83","author":"Najafi","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib115","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1016\/j.bmcl.2015.07.071","article-title":"Re-engineering nalidixic acid\u2019 s chemical scaffold: a step towards the development of novel anti-tubercular and anti-bacterial leads for resistant pathogens","volume":"25","author":"Peraman","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117472_bib116","first-page":"125","article-title":"Synthesis, docking studies, and biological evaluation of 1, 2, 4-triazole-linked quinoxaline derivatives","volume":"29","author":"Rajani devi","year":"2019","journal-title":"Indian Jrnl of Het Chem"},{"key":"10.1016\/j.ejmech.2025.117472_bib117","doi-asserted-by":"crossref","first-page":"105433","DOI":"10.1039\/C6RA22603E","article-title":"Efficient synthesis of novel 1,2,3-triazole-linked quinoxaline scaffold via copper-catalyzed click reactions","volume":"6","author":"Keivanloo","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.117472_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2019.127262","article-title":"1,2,3-Triazoles based 3-substituted 2-thioquinoxalines: synthesis, anti-bacterial activities, and molecular docking studies","volume":"1202","author":"Keivanloo","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117472_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103578","article-title":"Morpholine as ubiquitous pharmacophore in medicinal chemistry: deep insight into the structure-activity relationship (SAR)","volume":"96","author":"Kumari","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib120","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/med.21634","article-title":"Morpholine as a privileged structure: a review on the medicinal chemistry and pharmacological activity of morpholine containing bioactive molecules","volume":"40","author":"Kourounakis","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.117472_bib121","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/cmdc.201900682","article-title":"Morpholine as a scaffold in medicinal chemistry: an update on synthetic strategies","volume":"15","author":"Tzara","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.117472_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104164","article-title":"Design, synthesis, antimicrobial activity and molecular docking studies of some novel di-substituted sulfonylquinoxaline derivatives","volume":"104","author":"Ammar","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131314","article-title":"Experimental and theoretical investigation for 6-Morpholinosulfonylquinoxalin-2(1H)-one and its haydrazone derivate: synthesis, characterization, tautomerization and antimicrobial evaluation","volume":"1247","author":"Elsisi","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117472_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2021.103497","article-title":"Design, synthesis of new novel quinoxalin-2(1H)-one derivatives incorporating hydrazone, hydrazine, and pyrazole moieties as antimicrobial potential with in-silico ADME and molecular docking simulation","volume":"15","author":"Ragab","year":"2022","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib125","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3390\/ph16081174","article-title":"Quinoxaline 1,4-dioxides: advances in chemistry and chemotherapeutic drug development","volume":"16","author":"Buravchenko","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2025.117472_bib126","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.micres.2013.06.015","article-title":"Antimicrobial activity of quinoxaline 1,4-dioxide with 2- and 3-substituted derivatives","volume":"169","author":"Vieira","year":"2014","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.ejmech.2025.117472_bib127","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bmc.2018.11.021","article-title":"An insight into medicinal chemistry of anticancer quinoxalines","volume":"27","author":"Kaushal","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib128","first-page":"4347","article-title":"Recent advances in design of potential quinoxaline anti-infectives","volume":"21","author":"Jampilek","year":"2014","journal-title":"Comput. Mater. Continua (CMC)"},{"key":"10.1016\/j.ejmech.2025.117472_bib129","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/cbdd.13921","article-title":"Current status of quinoxaline and quinoxaline 1,4\u2010 di\u2010 N \u2010 oxides derivatives as potential antiparasitic agents","volume":"98","author":"Soto\u2010 S\u00e1nchez","year":"2021","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2025.117472_bib130","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3389\/fchem.2020.00598","article-title":"Design, synthesis, and biological evaluation of novel thiazolidinone-containing quinoxaline-1,4-di-N-oxides as antimycobacterial and antifungal agents","volume":"8","author":"Zhang","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib131","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.matpr.2021.08.023","article-title":"Anti bacterial and anticancer activities of quinoxaline-2-carbohydrazide-N-oxide compounds","volume":"49","author":"Ketha","year":"2022","journal-title":"Mater. Today Proc."},{"key":"10.1016\/j.ejmech.2025.117472_bib132","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/ph15020155","article-title":"Synthesis and characterization of novel 2-Acyl-3-trifluoromethylquinoxaline 1,4- dioxides as potential antimicrobial agents","volume":"15","author":"Buravchenko","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2025.117472_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2023.101013","article-title":"A critical review of benzimidazole: sky-high objectives towards the lead molecule to predict the future in medicinal chemistry","volume":"6","author":"Banerjee","year":"2023","journal-title":"Results in Chemistry"},{"key":"10.1016\/j.ejmech.2025.117472_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2023.101139","article-title":"Benzimidazole: a versatile scaffold for drug discovery and beyond \u2013 a comprehensive review of synthetic approaches and recent advancements in medicinal chemistry","volume":"6","author":"Mahurkar","year":"2023","journal-title":"Results in Chemistry"},{"key":"10.1016\/j.ejmech.2025.117472_bib135","first-page":"4","article-title":"In vitro anthelmintic and antimicrobial activity of novel series of quinoxaline- 2, 3-dione -6-sulphonyl Benzimidazole","volume":"8","author":"Gayathri","year":"2015","journal-title":"Journal Of Chemical & Pharmaceutical Science"},{"key":"10.1016\/j.ejmech.2025.117472_bib136","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.dcmed.2021.12.004","article-title":"Rational drug design, synthesis, and biological evaluation of novel N-(2-arylaminophenyl)-2,3-diphenylquinoxaline-6-sulfonamides as potential antimalarial, antifungal, and antibacterial agents","volume":"4","author":"Shntaif","year":"2021","journal-title":"Digital Chinese Medicine"},{"key":"10.1016\/j.ejmech.2025.117472_bib137","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3390\/ph15101250","article-title":"Chalcone: a promising bioactive scaffold in medicinal chemistry","volume":"15","author":"Rajendran","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2025.117472_bib138","article-title":"Anticancer activity of natural and synthetic chalcones","volume":"22","author":"Constantinescu","year":"2021","journal-title":"IJMS"},{"key":"10.1016\/j.ejmech.2025.117472_bib139","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01292-5","article-title":"New chalcone derivatives as potential antimicrobial and antioxidant agent","volume":"11","author":"Okolo","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117472_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jscs.2022.101590","article-title":"Design, synthesis and antiviral activities of chalcone derivatives containing pyrimidine","volume":"27","author":"Zhan","year":"2023","journal-title":"J. Saudi Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117472_bib141","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3390\/molecules25051047","article-title":"Antimicrobial, antioxidant, and anticancer activities of some novel isoxazole ring containing chalcone and dihydropyrazole derivatives","volume":"25","author":"Shaik","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117472_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104681","article-title":"Chalcone and its analogs: therapeutic and diagnostic applications in Alzheimer\u2019 s disease","volume":"108","author":"Thapa","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib143","first-page":"2257","article-title":"A systematic review on anti-diabetic properties of chalcones","volume":"27","author":"Rocha","year":"2020","journal-title":"Comput. Mater. Continua (CMC)"},{"key":"10.1016\/j.ejmech.2025.117472_bib144","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3390\/ph15070847","article-title":"Chalcones as potential ligands for the treatment of Parkinson\u2019 s disease","volume":"15","author":"Kr\u00f3licka","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2025.117472_bib145","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0960-894X(98)00179-6","article-title":"Synthesis and anti-inflammatory activity of chalcone derivatives","volume":"8","author":"Herencia","year":"1998","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117472_bib146","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/1521-4184(200110)334:10<332::AID-ARDP332>3.0.CO;2-O","article-title":"Antinociceptive properties of chalcones. Structure-activity relationships","volume":"334","author":"Corr\u00eaa","year":"2001","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.ejmech.2025.117472_bib147","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.bmcl.2017.03.059","article-title":"Novel quinoxalinyl chalcone hybrid scaffolds as enoyl ACP reductase inhibitors:Synthesis, molecular docking and biological evaluation","volume":"27","author":"Desai","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ejmech.2025.117472_bib148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/6471352","article-title":"New conjugates of quinoxaline as potent antitubercular and antibacterial agents","author":"Peraman","year":"2016","journal-title":"International Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2025.117472_bib149","first-page":"30483","article-title":"Synthesis and antimicrobial evaluationof benz[b]-1,4-thiazepine , benz[b]-1,4-diazepine,and quinoxaline derivatives via green mechanochemical and conventional techniques","volume":"8","author":"Fahmy","year":"2016","journal-title":"International Journal of Current Research"},{"key":"10.1016\/j.ejmech.2025.117472_bib150","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1002\/jhet.3003","article-title":"Synthesis of novel substituted phenyl\u2010 3\u2010 hydrazinyl\u2010 quinoxaline\u2010 2\u2010 amine derivatives: evaluation of antimicrobial activity and its molecular docking studies","volume":"54","author":"Paliwal","year":"2017","journal-title":"Journal of Heterocyclic Chem"},{"key":"10.1016\/j.ejmech.2025.117472_bib151","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1002\/jhet.3716","article-title":"Exploration of quinoxaline derivatives as antimicrobial and anticancer agents","volume":"56","author":"Bayoumi","year":"2019","journal-title":"Journal of Heterocyclic Chem"},{"key":"10.1016\/j.ejmech.2025.117472_bib152","first-page":"4198","article-title":"Synthesis and antimicrobial activity of some new substituted quinoxalines","volume":"19","author":"Mohammed","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117472_bib153","first-page":"2278","article-title":"Synthesis and antimicrobial evaluation of new derivatives of 5(((2-chloroquinoxalin-3-yl)amino)methyl)-3-(3,4substitutedphenyl)oxazolidin-2-ones","volume":"12","author":"Omprakash","year":"2019","journal-title":"IOSR J. Appl. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib154","first-page":"2378","article-title":"Synthesis, antibacterial activity and molecular docking study of a series of 1","author":"Keivanloo","year":"2022","journal-title":"3-Oxazole-Quinoxaline Amine Hybrids PolycyclicAromaticCompounds42"},{"key":"10.1016\/j.ejmech.2025.117472_bib155","first-page":"346","article-title":"Synthesis and antimicrobial activity of some quinoxaline derivatives","volume":"9","author":"El Janati","year":"2021","journal-title":"Moroc. J. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib156","first-page":"1295","article-title":"Hit identification against Candida albicans: design, synthesis, molecular docking and biological evaluation of hybrid styryl-quinoxaline based analogues","volume":"66","author":"El Newahie","year":"2023","journal-title":"Egypt. J. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134443","article-title":"A novel of quinoxaline derivatives tagged with pyrrolidinyl scaffold as a new class of antimicrobial agents: design, synthesis, antimicrobial activity, and molecular docking simulation","volume":"1274","author":"Abdelgalil","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117472_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106433","article-title":"Design, synthesis, antimicrobial screening and molecular modeling of novel 6,7 dimethylquinoxalin-2(1H)-one and thiazole derivatives targeting DNA gyrase enzyme","volume":"134","author":"Alqurashi","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib159","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201700325","article-title":"Quinoxaline and quinoxaline\u2010 1,4\u2010 di\u2010 N \u2010 oxides: an emerging class of antimycobacterials","volume":"351","author":"Keri","year":"2018","journal-title":"Archiv Der Pharmazie"},{"key":"10.1016\/j.ejmech.2025.117472_bib160","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1016\/j.bmcl.2016.01.066","article-title":"Synthesis, 3D-QSAR analysis and biological evaluation of quinoxaline 1,4-di-N-oxide derivatives as antituberculosis agents","volume":"26","author":"Pan","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117472_bib161","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.bmcl.2016.03.066","article-title":"Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis","volume":"26","author":"Santiva\u00f1ez-Veliz","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117472_bib162","doi-asserted-by":"crossref","first-page":"8647","DOI":"10.1021\/acs.jmedchem.7b01332","article-title":"Design, synthesis, and characterization of N-Oxide-Containing heterocycles with in vivo sterilizing antitubercular activity","volume":"60","author":"Dos Santos Fernandes","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib163","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3390\/molecules23061453","article-title":"Anti-Mycobacterium tuberculosis activity of esters of quinoxaline 1,4-di-N-oxide","volume":"23","author":"Palos","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117472_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103955","article-title":"Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents","volume":"100","author":"Srinivasarao","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113657","article-title":"Discovery of novel nitrogenous heterocyclic-containing quinoxaline-1,4-di-N-oxides as potent activator of autophagy in M.tb-infected macrophages","volume":"223","author":"Zhang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib166","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.3390\/ph16111565","article-title":"Novel derivatives of quinoxaline-2-carboxylic acid 1,4-dioxides as antimycobacterial agents: mechanistic studies and therapeutic potential","volume":"16","author":"Frolova","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2025.117472_bib167","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1016\/j.bmcl.2015.07.057","article-title":"Synthesis and biological evaluation of phaitanthrin congeners as anti-mycobacterial agents","volume":"25","author":"Kamal","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ejmech.2025.117472_bib168","doi-asserted-by":"crossref","first-page":"23522","DOI":"10.1039\/D0RA02525A","article-title":"Regio- and diastereoselective synthesis of spiropyrroloquinoxaline grafted indole heterocyclic hybrids and evaluation of their antiMycobacterium tuberculosis activity","volume":"10","author":"Arumugam","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.117472_bib169","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.bmcl.2018.04.043","article-title":"Discovery of novel anti-tuberculosis agents with pyrrolo[1,2- a ]quinoxaline-based scaffold","volume":"28","author":"Wang","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117472_bib170","article-title":"Synthesis of novel 4,5\u2010 dihydropyrrolo[1,2\u2010 a ]quinoxalines, pyrrolo[1,2\u2010 a ]quinoxalin]\u2010 2\u2010 ones and their antituberculosis and anticancer activity","volume":"353","author":"Makane","year":"2020","journal-title":"Archiv Der Pharmazie"},{"key":"10.1016\/j.ejmech.2025.117472_bib171","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3390\/ph14080768","article-title":"Synthesis, biological evaluation, and in silico modeling of N-substituted quinoxaline-2-carboxamides","volume":"14","author":"Bouz","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2025.117472_bib172","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00044-016-1558-2","article-title":"Pyridine-catalyzed synthesis of quinoxalines as anticancer and anti-tubercular agents","volume":"25","author":"Kamble","year":"2016","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2025.117472_bib173","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.bmcl.2017.03.059","article-title":"Novel quinoxalinyl chalcone hybrid scaffolds as enoyl ACP reductase inhibitors: synthesis, molecular docking and biological evaluation","volume":"27","author":"Desai","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ejmech.2025.117472_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2022.105370","article-title":"Discovery of potent antitubercular agents: design, synthesis and biological evaluation of 4-(3-(4-substitutedpiperazin-1-yl)-quinoxalin-2-yl)-naphthalen-1-ol analogues","volume":"82","author":"Nandikolla","year":"2022","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.ejmech.2025.117472_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.127784","article-title":"Synthesis of novel quinoxaline-alkynyl derivatives and their anti-Mycobacterium tuberculosis activity","volume":"35","author":"Raphoko","year":"2021","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117472_bib176","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejmech.2014.11.018","article-title":"Synthesis and biological evaluation of novel 2,3-disubstituted quinoxaline derivatives as antileishmanial and antitrypanosomal agents","volume":"90","author":"Cogo","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117472_bib177","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1128\/AAC.02582-15","article-title":"In vitro and in vivo activities of 2,3-diarylsubstituted quinoxaline derivatives against leishmania amazonensis","volume":"60","author":"Kaplum","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.117472_bib178","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1128\/AAC.02529-15","article-title":"Novel heteroaryl selenocyanates and diselenides as potent antileishmanial agents","volume":"60","author":"Baquedano","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.117472_bib179","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.bmcl.2017.02.049","article-title":"New hydrazine and hydrazide quinoxaline 1,4-di- N -oxide derivatives: in silico ADMET, antiplasmodial and antileishmanial activity","volume":"27","author":"Quiliano","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117472_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133107","article-title":"Insight into structural features and supramolecular architecture of synthesized quinoxaline derivatives with anti-leishmanial activity, in vitro","volume":"1263","author":"Kumar","year":"2022","journal-title":"J. Mol. Struct."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425002375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425002375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T13:25:42Z","timestamp":1749043542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425002375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":180,"alternative-id":["S0223523425002375"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117472","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review on the anti-microbial activities and structure-activity relationship (SAR) of quinoxaline derivatives","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117472","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117472"}}